Chronic Inflammation and Narrowing of the Airways in Dogs (Chronic Obstructive Bronchitis, COPD)

  • Synonyms: COLD (Chronic Obstructive Lung Disease), CORD, COAD
  • Occurrence: common
  • Location of disease: Chest
Author: Dr. med. vet. Gisa Löwe | Last modified: 27.08.2026
Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Chronic Obstructive Bronchitis (COPD) in dogs is a persistent inflammation and narrowing of the airways, leading to persistent Cough and Respiratory distress.

The most important facts at a glance

Chronic Obstructive Bronchitis (COPD) in dogs is a long-term disease characterized by inflammation and narrowing of the bronchi, which makes airflow into the lungs difficult. Environmental allergens such as dust and pollen, as well as air pollution and secondhand smoke, are common causes that can lead to an allergic reaction and thus to the disease. Genetic factors and chronic infections can also play a role. Symptoms include Cough, abnormal breathing sounds, Respiratory distress, and reduced exercise tolerance. Diagnosis is made through a comprehensive clinical examination, X-rays, and, if necessary, bronchoscopy. Therapy includes avoiding triggers, medications such as bronchodilators and corticosteroids, and inhalation therapies. A healthy lifestyle with adapted exercise and a balanced diet supports the therapy. The prognosis depends on the course of the disease and the therapy; many dogs can lead a good life with timely and appropriate therapy. For the prevention of COPD, risk factors such as tobacco smoke and environmental pollution should be minimized; a clean environment can help reduce the risk. Regular veterinary examinations are essential to detect and treat the disease early.

Causes

Chronic Obstructive Bronchitis in dogs is a condition characterized by inflammation of the bronchi, leading to a narrowing of the airways. This inflammation is chronic, meaning it lasts for a long period and can worsen over time. The bronchi are the airways that carry air into the lungs, and their narrowing can significantly impair airflow.

The causes of COPD in dogs are varied. One of the most common causes is the Exposition to environmental allergens such as dust, pollen, or mold, which can trigger allergic reactions. Air pollution and secondhand smoke can also contribute to the development of the disease. Furthermore, chronic respiratory infections and genetic factors may play a role.

Another crucial factor is the Immunreaktion of the dog. In some dogs, the Immunsystem reacts excessively to harmless substances, leading to chronic inflammation. This immune response can be influenced by genetic predisposition, which explains why certain dog breeds are more susceptible to COPD.

Symptoms

Rare symptoms:

The symptoms of Chronic Obstructive Bronchitis in dogs can start subtly and gradually worsen. The most common symptom is a chronic Cough, which is often dry and hacking. The Cough can be triggered by physical exertion, excitement, or cold, and often occurs at night or early in the morning.

Another common symptom is Respiratory distress, which can manifest as an increased breathing rate or labored breathing. In severe cases, Panting or a whistling breath sound may occur. Dogs may also appear lethargic and less active, as Respiratory distress impairs their physical performance.

In advanced stages of the disease, symptoms such as Weight loss and loss of appetite may occur. Some dogs may also experience a bluish discoloration of the mucous membranes, a sign of oxygen deficiency in the blood.

Therapy

The therapy for Chronic Obstructive Bronchitis in dogs aims to alleviate symptoms and slow the progression of the disease. One of the main components of therapy is avoiding triggers that could irritate the airways. This may involve minimizing Exposition to allergens and pollutants.

Medications play an essential role in the therapy. Bronchodilators may be prescribed to widen the airways and ease breathing. Anti-inflammatory drug, especially corticosteroids, can help reduce inflammation and alleviate symptoms.

In some cases, antibiotics may be necessary if there is a bacterial infection of the respiratory tract. Inhalation therapies, similar to those used in humans with asthma, can also be helpful in delivering medication directly to the airways.

Regular physical activity, adapted to the dog’s abilities, can help improve lung function and maintain general fitness. A balanced diet is also important to control weight and promote overall health.

Prognosis and follow-up care

The Prognose for dogs with Chronic Obstructive Bronchitis varies depending on the severity of the disease and the response to therapy. In many cases, a good quality of life can be maintained through early Diagnose and appropriate therapy.

Dogs with mild to moderate COPD who respond well to treatment can often live a normal life, although they may need lifelong medication. Close collaboration with the veterinarian and regular check-ups are crucial to monitor the course of the disease and adjust treatment.

In severe cases, the prognosis may be less favorable, especially if the disease cannot be well controlled or if complications occur. Respiratory distress and reduced physical performance can significantly impair the quality of life.

Prevention

The prevention of Chronic Obstructive Bronchitis in dogs primarily focuses on minimizing risk factors. One of the most effective measures is reducing Exposition to known triggers such as tobacco smoke, dust, and environmental pollution. This can be achieved by improving indoor air quality and avoiding smoking near pets.

Regular cleaning of the living environment can help reduce the concentration of allergens and irritants. The use of air filters and regular vacuuming can also contribute to improving air quality.

A healthy lifestyle, including a balanced diet and regular exercise, can strengthen the Immunsystem and support the dog’s general health. Regular veterinary examinations are important to detect signs of respiratory diseases early and take appropriate measures.

Outlook on current research

Research is evolving from the “one-size-fits-all protocol” to precise, endotype-based medicine. Three questions are central: Which Inflammatory conditions patterns dominate (neutrophilic, eosinophilic, mixed)? Which structural changes characterize the course (bronchiectasis, bronchomalacia, wall thickening)? Which function is actually impaired (peripheral obstruction, collapse dynamics, mucus clearance)? New imaging (high-resolution CT with quantification) and functional measurements such as impulse oscillometry enable a more objective assessment of the small airways than classic spirometry. In parallel, bronchoalveolar lavage is used not only diagnostically but also for therapy planning: cell patterns and pathogen detection guide anti-inflammation, mucus management, and antimicrobial strategies. Inhaled corticosteroids remain the core therapy; studies optimize dosage, device adaptation, and adherence. Bronchodilators show differentiated effects, especially at dynamic constrictions. Immunomodulators approaches (e.g., macrolide strategies) are carefully examined to weigh benefits and resistance risk. The respiratory microbiome is increasingly coming into focus: dysbioses, biofilms, and pathobiont signatures could influence future therapy decisions. For therapy resistance, interventional options (e.g., selective mucosa cryoapplications) are prospectively evaluated, but so far only for selected cases. Digital monitoring using Cough counting, activity, and breathing sensors is intended to detect exacerbations early. The goal for the coming years: integrated algorithms that combine symptoms, imaging, function, and microbiome data – with personalized, preferably inhalation regimens, fewer side effects, and stable quality of life over a long period.

Frequently Asked Questions (FAQs)

1. What is chronic obstructive bronchitis in dogs?
Persistent Cough for at least two months without another major cause; inflamed bronchial walls, viscous mucus, and narrower airways characterize the picture.
2. How do I recognize the disease?
Often dry, spasmodic Cough that increases with excitement; later wheezing sounds, faster fatigue, and occasional Dyspnoe.
3. Is this the same as COPD in humans?
No. In dogs, non-infectious inflammation predominates; smoking plays no role. Mechanisms are similar but not identical.
4. Which tests are useful?
X-ray/CT, possibly bronchoscopy with lavage, cytology and culture; functional tests can detect small airway problems early.
5. Do inhaled Steroide really help?
Yes, they dampen inflammation directly in the lungs and save systemic side effects – correct technique and regular use are crucial.
6. Do antibiotics have a place?
Only with confirmed bacterial findings. Routine use promotes resistance and disrupts the microbiome.
7. What can I contribute at home?
Avoid smoke and dust, manage weight, document Cough frequency, practice inhalation technique, dose exertion.
8. Role of the microbiome?
Dysbioses can influence inflammation and mucus; not yet standard, but an important research focus.
9. Will my dog be "healthy" again?
Cure is rare, but good control is possible. Goal: less Cough, fewer flare-ups, more resilience.
10. What does the future bring?
More accurate measurement methods, personalized plans per endotype, and refined inhalative therapies – with better long-term stability.

Literature

  • Lyssens, A., Roels, E., Clercx, C., & Billen, F. (2025). Proposed treatment algorithms for dogs with chronic bronchitis associated with irreversible airway changes: Bronchiectasis and/or bronchomalacia. Frontiers in Veterinary Science, 12, Article 1686007. https://doi.org/10.3389/fvets.2025.1686007
  • Rozanski, E. A. (2020). Canine chronic bronchitis: An update. Veterinary Clinics of North America: Small Animal Practice, 50(2), 393–404. https://doi.org/10.1016/j.cvsm.2019.10.003
  • Gamracy, J., Wiggen, K., Vientos-Plotts, A., & Reinero, C. (2022). Clinicopathologic features, comorbid diseases, and prevalence of pulmonary hypertension in dogs with bronchomalacia. Journal of Veterinary Internal Medicine, 36(2), 417–428. https://doi.org/10.1111/jvim.16381
  • Chan, J. C., Lulich, J. P., McKiernan, B. C., & Hawkins, E. C. (2023). Prospective evaluation of the efficacy of inhaled steroids in dogs with inflammatory airway disease. Journal of Veterinary Internal Medicine, 37(2), 744–753. https://doi.org/10.1111/jvim.16644
  • Bexfield, N. H., Foale, R. D., Davison, L. J., Watson, P. J., Skelly, B. J., Herrtage, M. E., & Robinson, N. E. (2006). Management of 13 cases of canine respiratory disease using inhaled corticosteroids. Journal of Small Animal Practice, 47(7), 377–382. https://doi.org/10.1111/j.1748-5827.2006.00028.x
  • Della Maggiore, A. (2020). An update on tracheal and airway collapse in dogs. Veterinary Clinics of North America: Small Animal Practice, 50(2), 419–430. https://doi.org/10.1016/j.cvsm.2019.10.012
  • Adamama-Moraitou, K. K., Pardali, D., Day, M. J., Prassinos, N. N., Kritsepi-Konstantinou, M., Patsikas, M. N., & Rallis, T. S. (2012). Canine bronchomalacia: A clinicopathological study of 18 cases diagnosed by endoscopy. The Veterinary Journal, 191(2), 261–266. https://doi.org/10.1016/j.tvjl.2010.12.021
  • Padrid, P. (2000). Diagnosis and treatment of canine chronic bronchitis: Twenty years of experience. Veterinary Clinics of North America: Small Animal Practice, 30(6), 1267–1278. https://doi.org/10.1016/S0195-5616(00)06006-9
  • Lyssens, A., Roels, E., Clercx, C., & Billen, F. (2025). Proposed treatment algorithms for dogs with chronic bronchitis associated with irreversible airway changes: Bronchiectasis and/or bronchomalacia. Frontiers in Veterinary Science, 12, Article 1686007. https://doi.org/10.3389/fvets.2025.1686007
  • Rozanski, E. A. (2020). Canine chronic bronchitis: An update. Veterinary Clinics of North America: Small Animal Practice, 50(2), 393–404. https://doi.org/10.1016/j.cvsm.2019.10.003
  • Gamracy, J., Wiggen, K., Vientos-Plotts, A., & Reinero, C. (2022). Clinicopathologic features, comorbid diseases, and prevalence of pulmonary hypertension in dogs with bronchomalacia. Journal of Veterinary Internal Medicine, 36(2), 417–428. https://doi.org/10.1111/jvim.16381
  • Chan, J. C., Lulich, J. P., McKiernan, B. C., & Hawkins, E. C. (2023). Prospective evaluation of the efficacy of inhaled steroids in dogs with inflammatory airway disease. Journal of Veterinary Internal Medicine, 37(2), 744–753. https://doi.org/10.1111/jvim.16644
  • Bexfield, N. H., Foale, R. D., Davison, L. J., Watson, P. J., Skelly, B. J., Herrtage, M. E., & Robinson, N. E. (2006). Management of 13 cases of canine respiratory disease using inhaled corticosteroids. Journal of Small Animal Practice, 47(7), 377–382. https://doi.org/10.1111/j.1748-5827.2006.00028.x
  • Della Maggiore, A. (2020). An update on tracheal and airway collapse in dogs. Veterinary Clinics of North America: Small Animal Practice, 50(2), 419–430. https://doi.org/10.1016/j.cvsm.2019.10.012
  • Adamama-Moraitou, K. K., Pardali, D., Day, M. J., Prassinos, N. N., Kritsepi-Konstantinou, M., Patsikas, M. N., & Rallis, T. S. (2012). Canine bronchomalacia: A clinicopathological study of 18 cases diagnosed by endoscopy. The Veterinary Journal, 191(2), 261–266. https://doi.org/10.1016/j.tvjl.2010.12.021
  • Padrid, P. (2000). Diagnosis and treatment of canine chronic bronchitis: Twenty years of experience. Veterinary Clinics of North America: Small Animal Practice, 30(6), 1267–1278. https://doi.org/10.1016/S0195-5616(00)06006-9